Scalp, Eyebrow, and Eyelash Hair Regrowth with Continued Ritlecitinib Treatment Among Patients with Alopecia Areata Without Target Efficacy Response at Week 24: Post Hoc Analysis of the ALLEGRO Phase 2b/3 Study

    July 2023 in “ SKIN The Journal of Cutaneous Medicine ”
    M.M. Senna, Seth Forman, Lindsey A. Bordone … Liza Takiya
    Studysummary This study found that some patients with alopecia areata who did not respond to ritlecitinib treatment by Week 24 achieved a positive response with continued therapy by Week 48, with tolerable side effects.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on jofskin.org →
    Discuss this study in the Community →

    Related research 8

    1. Response to Ritlecitinib Treatment Based on Salt Improvement Scores in Patients With Alopecia Areata: Post Hoc Analysis of the Allegro Phase 2b/3 Study ˜The œjournal of investigative dermatology/Journal of investigative dermatology · 2023
    2. Baricitinib Results in Eyebrow and Eyelash Growth in Patients With Alopecia Areata Who Do Not Achieve 20% or Less Scalp Hair Loss Journal of The American Academy of Dermatology · 2022
    3. Alopecia Areata After Severe Allergic Contact Dermatitis to a Permanent Hair Dye Contact dermatitis · 2022
    4. Time to Scalp Hair, Eyebrow, and Eyelash Improvement in Patients with Alopecia Areata Treated with Baricitinib in the Phase 2 Portion of the Phase 2/3 BRAVE-AA1 Study Journal of The American Academy of Dermatology · 2021
    5. Rare Presentation of Concomitant Alopecia Areata and Vitiligo in a Teenager Skin · 2021
    6. Topical Tofacitinib Solution for the Treatment of Alopecia Areata Affecting Eyelashes JAAD Case Reports · 2018
    7. Bimatoprost for the Treatment of Eyelash, Eyebrow, and Scalp Alopecia Expert Opinion on Investigational Drugs · 2017
    8. Eyelash Alopecia Areata: Case Series and Literature Review Canadian journal of ophthalmology · 2012